Diabetes
Siglita Tablet 50mg
Out of Stock
Call for price
<h2> </h2><p>10 tablets</p><p>Indication:</p><p>Management of type 2 diabetes mellitus.</p><p>Dosage & Administration:</p><p>The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.</p><p>For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Siglita™ is required.</p><p>For patients with moderate renal insufficiency (CrCl 30 to <50 mL/min), the dose of Siglita™ is 50 mg once daily.</p><p> </p><p>For patients with severe renal insufficiency (CrCl <30 mL/min) or with end-stage renal disease (ESRD) requiring hemodialysis or</p><p>peritoneal dialysis, the dose of Siglita™ is 25 mg once daily.</p><p>Siglita™ may be administered without regard to the timing of hemodialysis.</p><p>Preparation:</p><p>Siglita™ Tablet: Box containing 20 tablets in blister pack.</p>
10 tablets
Indication:
Management of type 2 diabetes mellitus.
Dosage & Administration:
The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.
For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Siglita™ is required.
For patients with moderate renal insufficiency (CrCl 30 to <50 mL/min), the dose of Siglita™ is 50 mg once daily.
For patients with severe renal insufficiency (CrCl <30 mL/min) or with end-stage renal disease (ESRD) requiring hemodialysis or
peritoneal dialysis, the dose of Siglita™ is 25 mg once daily.
Siglita™ may be administered without regard to the timing of hemodialysis.
Preparation:
Siglita™ Tablet: Box containing 20 tablets in blister pack.
No additional specifications available.
No vendor information available.